000			03578nam a2200433 i 4500
999			_c361299 _d361299
001			361299
003			ES-MaUEC
005			20230102121339.0
006			a|||| o|||| 00| 0
007			cr nn nnnaamaa
008			211007s2021 sz | o |||| 0|eng d
020			_a9783030786632
024	7		_a10.1007/978-3-030-78663-2 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC
050		4	_aRC346 _b2021 EB
245	0	0	_aDiagnosis, Management and Emerging Strategies for Chemotherapy-Induced Neuropathy : _bA MASCC Book _cedited by Maryam Lustberg, Charles Loprinzi
250			_aFirst edition 2021
264		1	_aCham _bSpringer International Publishing _c2021
300			_a1 recurso en línea (VIII, 263 páginas) _b11 ilustraciones, 9 ilustraciones a color
336			_2rdacontent _aTexto _btxt
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
347			_aArchivo de texto _bPDF
490	0		_aBiomedical and Life Sciences (SpringerNature-11642)
490	0		_aBiomedical and Life Sciences (R0) (SpringerNature-43708)
505	0		_aNatural History of Chemotherapy Induced Neuropathy -- Predisposing factors for the development of CIPN -- Evaluation of Chemotherapy-Induced Peripheral Neuropathy -- Preventive Strategies for Chemotherapy-in-duced Peripheral Neuropathy -- Prevention of CIPN - Current Clinical Data and Future Directions -- Treatment of established CIPN: basic science and animal models -- Pharmacological Treatment of Established CIPN -- Systematic review of exercise for prevention and management of chemotherapy-induced peripheral neuropathy -- Clinical and practical recommendations in the use of exercise, physical therapy, and occupational therapy for chemotherapy-induced peripheral neuropathy -- Natural course of neurotoxicity after immune checkpoint inhibitor (ICI) exposure -- Ants and Needles and Pins - Living with Neuropathy.
520	3		_aThis book comprehensively examines chemotherapy-induced peripheral neuropathy (CIPN), a common dose-limiting condition that negatively affects both the quality of life of cancer patients and disease outcomes. CIPN remains a challenging area for both clinical care and research, as there are multiple unresolved issues. Written by leading international experts, the book discusses the natural history of CIPN, the latest predictors of toxicity, instruments for evaluating symptoms, and prevention/therapeutic strategies, as well as patients' experiences of this common clinical syndrome. Lastly it highlights avenues for future research to enhance our understanding of CIPN. Providing essential information on the management of CIPN and the latest research in the field, this book is a valuable resource for researchers and healthcare providers working with patients with various malignant diseases.
988			_aSpringer_BiomedLife_2021
650		7	_2embne _aSistema nervioso _xEnfermedades _9169088
650		7	_2embne _9138367 _aQuimioterapia
700	1		_aLustberg, Maryam _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt _9680910
700	1		_aLoprinzi, Charles L. _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt _9680911
776	0	8	_iPrinted edition: _z9783030786625
776	0	8	_iPrinted edition: _z9783030786649
776	0	8	_iPrinted edition: _z9783030786656
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-78663-2 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_b01/2022 _dz _eb _zSI